CRIS vs CCCC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

CRIS

53.9
AI Score
VS
CRIS Wins

CCCC

44.7
AI Score

Investment Advisor Scores

CRIS

54score
Recommendation
HOLD

CCCC

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CRIS CCCC Winner
Net Income -32.78M -48.76M CRIS
Operating Income -21.46M -54.21M CRIS
ROE -698.2% -19.7% CCCC
ROA -172.8% -13.6% CCCC
Total Assets 18.97M 359.40M CCCC
Cash 5.07M 78.61M CCCC
Current Ratio 0.49 5.45 CCCC

Relative Price Performance (Last 90 Days)

CRIS 1M: -56.1% · 3M: -91.8% CCCC 1M: +1.0% · 3M: -14.8%

Current Technical Phase

CRIS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -58.2%), weak momentum, RSI 11

RSI (14): 11.2 · Price: $0.39

CCCC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.6 · Price: $3.06

Fundamentals Snapshot

Metric CRIS CCCC
Market Cap — —
Forward P/E -0.1 -3.2
Trailing P/E 0.3 —
Revenue (TTM) — —
Revenue Growth -0.7% 0.0%
Gross Margin -4.9% 0.9%
Operating Margin -8.3% -4.0%
EPS 1.32 -0.91
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CRIS is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.